Feb 09, 2017 21:08 pm UTC| Business
CORAL GABLES, Fla., Feb. 09, 2017 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...
Feb 09, 2017 21:08 pm UTC| Business
CORAL GABLES, Fla., Feb. 09, 2017 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...
Feb 09, 2017 21:08 pm UTC| Business
Raises $18.5 million from L Catterton through private placementAmends credit facility to increase flexibilityAnnounces plan to close approximately 55 underperforming restaurantsAnnounces selected preliminary fourth quarter...
Feb 09, 2017 21:08 pm UTC| Business
CORAL GABLES, Fla., Feb. 09, 2017 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...
Web.com Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 09, 2017 21:07 pm UTC| Business
Solid progress on Yodle integration and strong financial performance that beat profit targets and hit the high end of revenue guidanceGenerated $128 million of operating cash flow and $106 million of free cash flow for the...
Feb 09, 2017 21:07 pm UTC| Business
CORAL GABLES, Fla., Feb. 09, 2017 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...
Web.com Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 09, 2017 21:07 pm UTC| Business
Solid progress on Yodle integration and strong financial performance that beat profit targets and hit the high end of revenue guidanceGenerated $128 million of operating cash flow and $106 million of free cash flow for the...